143 related articles for article (PubMed ID: 37439937)
1. Current state-of-the-art imaging techniques in the domain of whole-body MRI and its advantages over other whole-body PET in different musculoskeletal diseases.
Ahlawat S
Eur Radiol; 2023 Dec; 33(12):8573-8575. PubMed ID: 37439937
[No Abstract] [Full Text] [Related]
2. PET/Computed Tomography and PET/MR Imaging: Basic Principles, Methodology, and Imaging Protocol for Musculoskeletal Applications.
Parghane RV; Basu S
PET Clin; 2018 Oct; 13(4):459-476. PubMed ID: 30219182
[TBL] [Abstract][Full Text] [Related]
3. Can whole-body MRI replace (18)F-fluorodeoxyglucose PET/CT?
Kwee TC
Lancet Oncol; 2014 Mar; 15(3):243-4. PubMed ID: 24559804
[No Abstract] [Full Text] [Related]
4. In Vivo Molecular Imaging of Musculoskeletal Inflammation and Infection.
Pawaskar A; Basu S; Jahangiri P; Alavi A
PET Clin; 2019 Jan; 14(1):43-59. PubMed ID: 30420221
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Interobserver Agreement and Diagnostic Accuracy for IASLC/ITMIG Thymic Epithelial Tumor Staging Among Co-registered FDG-PET/MRI, Whole-body MRI, Integrated FDG-PET/CT, and Conventional Imaging Examination with and without Contrast Media Administrations.
Ohno Y; Kishida Y; Seki S; Koyama H; Yui M; Aoyagi K; Yoshikawa T
Acad Radiol; 2022 Mar; 29 Suppl 3():S122-S131. PubMed ID: 29395795
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous whole-body and breast 18F-FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values.
Sasaki M; Tozaki M; Kubota K; Murakami W; Yotsumoto D; Sagara Y; Ohi Y; Oosako S; Sagara Y
Jpn J Radiol; 2018 Feb; 36(2):122-133. PubMed ID: 29159779
[TBL] [Abstract][Full Text] [Related]
8. Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI.
Theruvath AJ; Siedek F; Muehe AM; Garcia-Diaz J; Kirchner J; Martin O; Link MP; Spunt S; Pribnow A; Rosenberg J; Herrmann K; Gatidis S; Schäfer JF; Moseley M; Umutlu L; Daldrup-Link HE
Radiology; 2020 Jul; 296(1):143-151. PubMed ID: 32368961
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
[TBL] [Abstract][Full Text] [Related]
10. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
Li J; Zhou H; Zhang X; Song F; Pang X; Wei Z
Ann Palliat Med; 2020 Mar; 9(2):247-255. PubMed ID: 32233618
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT.
Ng SH; Chan SC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Lin CY; Chang KP; Lin YC
Eur Radiol; 2010 Sep; 20(9):2229-40. PubMed ID: 20393714
[TBL] [Abstract][Full Text] [Related]
12. Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
Ohno Y; Yui M; Aoyagi K; Kishida Y; Seki S; Koyama H; Yoshikawa T
AJR Am J Roentgenol; 2019 Feb; 212(2):311-319. PubMed ID: 30512992
[TBL] [Abstract][Full Text] [Related]
13. Hybrid whole body
Yang M; Zhou Y; Hoxworth JM; Porter AB; Roarke MC
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(4):261-263. PubMed ID: 28803890
[No Abstract] [Full Text] [Related]
14. Whole-Body [
Berzaczy D; Fueger B; Hoeller C; Haug AR; Staudenherz A; Berzaczy G; Weber M; Mayerhoefer ME
Mol Imaging Biol; 2020 Jun; 22(3):739-744. PubMed ID: 31363965
[TBL] [Abstract][Full Text] [Related]
15. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.
Takenaka D; Ohno Y; Matsumoto K; Aoyama N; Onishi Y; Koyama H; Nogami M; Yoshikawa T; Matsumoto S; Sugimura K
J Magn Reson Imaging; 2009 Aug; 30(2):298-308. PubMed ID: 19629984
[TBL] [Abstract][Full Text] [Related]
16. Hybrid simultaneous whole-body 2-[
Jamet B; Carlier T; Bailly C; Bodet-Milin C; Monnet A; Frampas E; Touzeau C; Moreau P; Kraeber-Bodere F
Eur Radiol; 2023 Sep; 33(9):6438-6447. PubMed ID: 37022439
[TBL] [Abstract][Full Text] [Related]
17. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Significance of 18F-FDG PET/CT Imaging Coupled with Magnetic Resonance Imaging of the Entire Body for Bone Metastases.
Guo H; Zhang Z; Wang L; Yao S; Xu S; Ma S; Liu S
Contrast Media Mol Imaging; 2022; 2022():7717398. PubMed ID: 36247843
[TBL] [Abstract][Full Text] [Related]
19. Whole body imaging in musculoskeletal oncology: when, why, and how.
Vicentini JRT; Bredella MA
Skeletal Radiol; 2023 Mar; 52(3):281-295. PubMed ID: 35809098
[TBL] [Abstract][Full Text] [Related]
20. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.
Sommer G; Wiese M; Winter L; Lenz C; Klarhöfer M; Forrer F; Lardinois D; Bremerich J
Eur Radiol; 2012 Dec; 22(12):2859-67. PubMed ID: 22772365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]